Market Overview

DBV Technologies Falls 45% Following Failed Peanut Allergy Trial


DBV Technologies SA - ADR (NASDAQ: DBVT) shares are trading lower by $22.00 (46 percent) at $26.07 in Monday's session.

Before the open, the company announced that a peanut allergy trial failed to meet its primary endpoint.

After a much lower, DBV continued in that direction before finally finding a bottom at $22.33 and reversed course. That low matches it Feb. 2016 low of $22.55. Since reaching that depressed level, it has continued to make new highs for the session. As of 11:35 a.m. ET, the high stands at $26.82.

Today's decline is taking place o much heavier than average volume, as over 8 million shares have traded compared to its 20-day average of 670,000.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (DBVT)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

Earnings Preview: Food And Beverage Companies McDonald's, Chipotle And Coca-Cola Report This Week

USD/JPY Forecast: Key Levels To Watch Out For - 113.50 & 114.45